Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-02-09 @ 6:29 AM
Study NCT ID:
NCT05110157
Status:
COMPLETED
Last Update Posted:
2025-07-10
First Post:
2021-10-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D012559', 'term': 'Schizophrenia'}], 'ancestors': [{'id': 'D019967', 'term': 'Schizophrenia Spectrum and Other Psychotic Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000603978', 'term': 'valbenazine'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 442}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-11-29', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-07', 'completionDateStruct': {'date': '2025-02-18', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2025-07-09', 'studyFirstSubmitDate': '2021-10-26', 'studyFirstSubmitQcDate': '2021-10-26', 'lastUpdatePostDateStruct': {'date': '2025-07-10', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-11-05', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2025-02-04', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change in Positive and Negative Syndrome Scale (PANSS) total score from baseline to Week 10', 'timeFrame': 'Baseline to week 10'}], 'secondaryOutcomes': [{'measure': 'Change in Clinical Global Impression of Severity (CGI-S) score from baseline to Week 10', 'timeFrame': 'Baseline to week 10'}, {'measure': 'Change in Personal and Social Performance Scale (PSP) score from baseline to Week 10', 'timeFrame': 'Baseline to week 10'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Schizophrenia', 'Valbenazine', 'Antipsychotic', 'VMAT2', 'NBI-98854', 'Dopamine', 'Journey', 'Neurocrine', 'PANSS', 'Adjunctive'], 'conditions': ['Schizophrenia']}, 'descriptionModule': {'briefSummary': 'The primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response to antipsychotic treatment.', 'detailedDescription': 'Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of valbenazine when administered orally once daily as adjunctive treatment in participants with schizophrenia who have had an inadequate response to antipsychotics. The study will enroll approximately 400 participants with a diagnosis of schizophrenia. The expected duration of study participation for each participant is approximately 16 weeks.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n• Participants must meet all of the following inclusion criteria:\n\n1. Completed written informed consent.\n2. At the time of signing the informed consent, participant must be ≥18 years of age\n3. Medically confirmed diagnosis of schizophrenia as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).\n4. The initial diagnosis of schizophrenia must be ≥1 year before the screening visit.\n5. Plasma levels for at least 1 of the participant's antipsychotic medications must be detectable by an available assay.\n6. The participant is treated with a stable regimen antipsychotic medication.\n7. Must meet all of the following criteria at the screening visit and Day 1:\n\n * PANSS total score ≥70\n * PANSS score of ≥4 on at least 1 of the following:\n\n * P1 (delusions)\n * P3 (hallucinations)\n * P6 (suspiciousness)\n * G9 (unusual thought content)\n * CGI-S score ≥4\n * Stable background antipsychotic medication dose between the screening visit and Day 1\n * Stable PANSS total score between the screening visit and Day 1\n8. The participant is outpatient with stable symptomatology\n9. The participant must have an adult informant (for example, a family member, relative, partner, social worker, caseworker, residential facility staff, or nurse).\n10. Female participants of childbearing potential must agree to use contraception consistently from the screening visit until 30 days after the last dose of study drug or final study visit, whichever is longer.\n11. Male participants must agree to use contraception consistently from screening until 30 days after last dose of study treatment.\n\nExclusion Criteria:\n\n* Participants will be excluded from the study if they meet any of the following criteria:\n\n 1. Pregnant or breastfeeding or plans to become pregnant during the study. This criterion must be reconfirmed prior to the first dose of study treatment on Day 1.\n 2. Known hypersensitivity to any component of the formulation of valbenazine.\n 3. Has history of treatment resistant schizophrenia.\n 4. Evidence of depression as measured by a Calgary Depression Scale for Schizophrenia (CDSS) score ≥11 at the screening visit or Day 1.\n 5. Participants with any suicidal behavior or suicidal ideation within 6 months before the screening visit or Day 1.\n 6. Diagnosis of moderate or severe substance use disorder within the 6 months before the screening visit.\n 7. Have a clinically significant unstable medical condition within 60 days before the screening visit in the judgement of the investigator or any laboratory value outside the normal range that is considered by the investigator to be clinically significant at the screening visit.\n 8. Prior (within 6 months of the screening visit) or concomitant use of any VMAT2 inhibitor."}, 'identificationModule': {'nctId': 'NCT05110157', 'briefTitle': 'Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia', 'organization': {'class': 'INDUSTRY', 'fullName': 'Neurocrine Biosciences'}, 'officialTitle': 'A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment in Subjects With Schizophrenia', 'orgStudyIdInfo': {'id': 'NBI-98854-ATS3019'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Placebo once daily.', 'interventionNames': ['Drug: Placebo']}, {'type': 'EXPERIMENTAL', 'label': 'Vesicular monoamine transporter 2 (VMAT2) inhibitor', 'description': 'Valbenazine once daily', 'interventionNames': ['Drug: Valbenazine']}], 'interventions': [{'name': 'Placebo', 'type': 'DRUG', 'description': 'Oral capsules', 'armGroupLabels': ['Placebo']}, {'name': 'Valbenazine', 'type': 'DRUG', 'otherNames': ['NBI-98854'], 'description': 'Oral capsules', 'armGroupLabels': ['Vesicular monoamine transporter 2 (VMAT2) inhibitor']}]}, 'contactsLocationsModule': {'locations': [{'zip': '85012', 'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '72758', 'city': 'Rogers', 'state': 'Arkansas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 36.33202, 'lon': -94.11854}}, {'zip': '92805', 'city': 'Anaheim', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.83529, 'lon': -117.9145}}, {'zip': '90706', 'city': 'Bellflower', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.88168, 'lon': -118.11701}}, {'zip': '90230', 'city': 'Culver City', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 34.02112, 'lon': -118.39647}}, {'zip': '92845', 'city': 'Garden Grove', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.77391, 'lon': -117.94145}}, {'zip': '91945', 'city': 'Lemon Grove', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 32.74255, 'lon': -117.03142}}, {'zip': '90807', 'city': 'Long Beach', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.76696, 'lon': -118.18923}}, {'zip': '92056', 'city': 'Oceanside', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.19587, 'lon': -117.37948}}, {'zip': '90660', 'city': 'Pico Rivera', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.98307, 'lon': -118.09673}}, {'zip': '92506', 'city': 'Riverside', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.95335, 'lon': -117.39616}}, {'zip': '92102', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '92103', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '95124', 'city': 'San Jose', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 37.33939, 'lon': -121.89496}}, {'zip': '92705', 'city': 'Santa Ana', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.74557, 'lon': -117.86783}}, {'zip': '94305', 'city': 'Stanford', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 37.42411, 'lon': -122.16608}}, {'zip': '90502', 'city': 'Torrance', 'state': 'California', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.83585, 'lon': -118.34063}}, {'zip': '33180', 'city': 'Aventura', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.95648, 'lon': -80.13921}}, {'zip': '33134', 'city': 'Coral Gables', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.72149, 'lon': -80.26838}}, {'zip': '32114', 'city': 'Daytona Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 29.21081, 'lon': -81.02283}}, {'zip': '33012', 'city': 'Hialeah', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.8576, 'lon': -80.27811}}, {'zip': '33013', 'city': 'Hialeah', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.8576, 'lon': -80.27811}}, {'zip': '33016', 'city': 'Hialeah', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.8576, 'lon': -80.27811}}, {'zip': '33133', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33137', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33144', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '33016', 'city': 'Miami Lakes', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 25.90871, 'lon': -80.30866}}, {'zip': '34972', 'city': 'Okeechobee', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 27.24393, 'lon': -80.82978}}, {'zip': '33629', 'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '33407', 'city': 'West Palm Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 26.71534, 'lon': -80.05337}}, {'zip': '30328', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '60208', 'city': 'Evanston', 'state': 'Illinois', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.04114, 'lon': -87.69006}}, {'zip': '62702', 'city': 'Springfield', 'state': 'Illinois', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 39.80172, 'lon': -89.64371}}, {'zip': '49503', 'city': 'Grand Rapids', 'state': 'Michigan', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.96336, 'lon': -85.66809}}, {'zip': '63125', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '63128', 'city': 'St Louis', 'state': 'Missouri', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '68526', 'city': 'Lincoln', 'state': 'Nebraska', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 40.8, 'lon': -96.66696}}, {'zip': '89102', 'city': 'Las Vegas', 'state': 'Nevada', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '11516', 'city': 'Cedarhurst', 'state': 'New York', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 40.62288, 'lon': -73.7243}}, {'zip': '11004', 'city': 'Glen Oaks', 'state': 'New York', 'country': 'United States', 'facility': 'Neurocrine Clinical Sites', 'geoPoint': {'lat': 40.74705, 'lon': -73.71152}}, {'zip': '10032', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '10035', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '28211', 'city': 'Charlotte', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 35.22709, 'lon': -80.84313}}, {'zip': '45417', 'city': 'Dayton', 'state': 'Ohio', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 39.75895, 'lon': -84.19161}}, {'zip': '73112', 'city': 'Oklahoma City', 'state': 'Oklahoma', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 35.46756, 'lon': -97.51643}}, {'zip': '78754', 'city': 'Austin', 'state': 'Texas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 30.26715, 'lon': -97.74306}}, {'zip': '75390', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '75115', 'city': 'DeSoto', 'state': 'Texas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 32.58986, 'lon': -96.85695}}, {'zip': '77081', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '77090', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '1133', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': '5004', 'city': 'Córdoba', 'country': 'Argentina', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': -31.40648, 'lon': -64.18853}}, {'zip': '6600', 'city': 'Kardzhali', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 41.64502, 'lon': 25.36578}}, {'zip': '5500', 'city': 'Lovech', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.13227, 'lon': 24.71763}}, {'zip': '5800', 'city': 'Pleven', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 43.41791, 'lon': 24.61666}}, {'zip': '5800', 'city': 'Pleven', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 43.41791, 'lon': 24.61666}}, {'zip': '4000', 'city': 'Plovdiv', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': '4000', 'city': 'Plovdiv', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': '4002', 'city': 'Plovdiv', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': '4004', 'city': 'Plovdiv', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.15387, 'lon': 24.75001}}, {'zip': '7003', 'city': 'Rousse', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.84872, 'lon': 25.9534}}, {'zip': '1000', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1000', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1113', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1408', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1510', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1680', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '5000', 'city': 'Veliko Tarnovo', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.08124, 'lon': 25.62904}}, {'zip': '3000', 'city': 'Vratsa', 'country': 'Bulgaria', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.21052, 'lon': 23.56312}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 3', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 4', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 5', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11000', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 6', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '11108', 'city': 'Belgrade', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 44.80401, 'lon': 20.46513}}, {'zip': '18202', 'city': 'Gornja Toponica', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.21417, 'lon': 21.46075}}, {'zip': '26220', 'city': 'Kovin', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 44.7475, 'lon': 20.97611}}, {'zip': '26220', 'city': 'Kovin', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 44.7475, 'lon': 20.97611}}, {'zip': '34000', 'city': 'Kragujevac', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 1', 'geoPoint': {'lat': 44.01667, 'lon': 20.91667}}, {'zip': '34000', 'city': 'Kragujevac', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 2', 'geoPoint': {'lat': 44.01667, 'lon': 20.91667}}, {'zip': '34000', 'city': 'Kragujevac', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site 3', 'geoPoint': {'lat': 44.01667, 'lon': 20.91667}}, {'zip': '18000', 'city': 'Niš', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.32472, 'lon': 21.90333}}, {'zip': '34000', 'city': 'Niš', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 43.32472, 'lon': 21.90333}}, {'zip': '23330', 'city': 'Novi Kneževac', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 46.05, 'lon': 20.1}}, {'zip': '26300', 'city': 'Vojvodina', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site'}, {'zip': '26300', 'city': 'Vršac', 'country': 'Serbia', 'facility': 'Neurocrine Clinical Site', 'geoPoint': {'lat': 45.11667, 'lon': 21.30361}}], 'overallOfficials': [{'name': 'Clinical Development Lead', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Neurocrine Biosciences'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Neurocrine Biosciences', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}